Close Menu

Personalis

This article was originally published Oct. 23.

NEW YORK (GenomeWeb) – Personalis and the Garvan Institute of Medical Research said today that they have partnered to provide commercial human whole-genome sequencing, analysis, and interpretation services to researchers and clinicians worldwide.

NEW YORK (GenomeWeb) – Personalis has received accreditation from the College of American Pathologists for its clinical lab in Menlo Park, Calif., the genetic analysis company said today.

The Inova Translational Medicine Institute has been exploring the diagnostic use of whole-genome sequencing in newborns with unexplained syndromes in a research setting and plans to transition to a clinical diagnostic test by the end of this year.

This article has been updated to reflect the increased size of a study by Inova.

Personalis has hired Deanna Church to the position of senior director of genomics and content.

Kevin Shianna has left the New York Genome Center, where he was most recently deputy scientific director of sequencing operations.

Personalis has launched an early-access program for its "Accuracy and Content Enhanced," or ACE, Clinical Exome test to diagnose rare Mendelian disorders, which it hopes will increase the diagnostic yield of conventional diagnostic exome sequencing.

Illumina has launched its TruGenome tests, including ones for undiagnosed disease and a predisposition screen as services through its CLIA-certified and CAP-accredited laboratory.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.